Minerva Neurosciences Inc (NERV) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Minerva Neurosciences Inc   (NASDAQ: NERV)


Minerva Neurosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Minerva Neurosciences Inc's ROI in the second quarter of 2026?
Minerva Neurosciences Inc recorded a cumulative net loss of $-395 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -545%.

Within the Healthcare sector 314 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4256 to 4336.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 120.76 % 63.86 % 10.74 % -34.78 % -35.32 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 79 90 96 25 28
Return On Investment (TTM) -545 % -696.04 % -652.63 % -47.36 % 34.19 %
NERV's Overall Ranking # 4336 # 4256 # 2824 # 3458 # 115
Seq. Investment Change TTM 21.59 % 32.64 % 51.8 % -9.83 % -9.75 %
Seq. Net Income Change TTM - - - - 79.54 %
Net Income (TTM) in Millions -395 -415 -293 -14 11

NERV Company Profile >> Back to NERV Roi Comparisons >> See Annual NERV Return On Investment



Return On Investment NERV's Ranking
Within: No.
Industry # 135
Sector # 315
Overall # 4336

Return On Investment Statistics
High Average Low
34.19 %
-76.11 %
-696.04 %
(Jun 30 2025)   (Mar 31 2026)







Financial Statements
Minerva Neurosciences Inc's II. Quarter Investments $ 79 Millions NERV's Balance sheet
Minerva Neurosciences Inc's II. Quarter Income $ 17 Millions Quarterly NERV's Income Statement
NERV's Income by Division See NERV's Income by Division


NERV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 96 34 54 54 74
Y / Y Investment Growth 178.89 % -35.95 % -0.28 % -27.72 % 36.42 %
Net Income in Millions -293 1 -30 -32 -50
Y / Y Net Income Growth - - - - -
Annual Return On Investment -306.68 % 4.19 % -56.02 % -59.78 % -67.17 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NERV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NERV's Competitors
Subscribers only: Roi for Minerva Neurosciences Inc's Suppliers
Subscribers only: Return On Investment for NERV's Customers

Other Ratios
NERV's Roa NERV's Inventory Turnover Ratio NERV's Growth Rates NERV's Dividend Statistics
NERV's Profitability Ratios NERV's Asset Turnover Ratio NERV's Dividend Growth
NERV's Roe NERV's Valuation Ratios NERV's Financial Strength Ratios NERV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:02:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.